Search

everythinglearnresearchcommunity

for

Search:↓

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Finasteride improves prostate cancer detection in PSA test.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

The document concludes that better training and education are needed for proper cancer screening and criticizes the GMC's inaction as harmful to clinical ethics in the UK.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Finasteride can treat prostatic haematuria, but its use is controversial.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Physical activity, height, and smoking affect prostate cancer risk.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

The document provides detailed care instructions for elderly patients.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Hair transplant surgeons should also focus on their patients' overall health, including regular check-ups and screening for common health issues.

Finasteride treats hair loss and reduces prostate cancer risk.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.